Discover
ANRO
Alto Neuroscience, Inc.
24.37
100 x 24.00
200 x 24.40
bid
ask
+
0.34
1.41%
150 @ 04:01 PM
24.37 +0.00 (0.00%)
| Ytd | 36.91% | |
| 1y | 304.82% |
23.81
day range
25.07
5.62
52 week range
36.64
| Open | 24.00 | Prev Close | 24.03 | Low | 23.81 | High | 25.07 | Mkt Cap | 956.33M |
| Vol | 649.43K | Avg Vol | 538.53K | EPS | -2.31 | P/E | N/A | Forward P/E | -7.78 |
| Beta | 1.16 | Short Ratio | 8.92 | Inst. Own | 87.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 30.63 | 200-d Avg | 23.82 | 1yr Est | 38.38 |
| Income Statement | |||
| Operating Expenses | 29.13M | ||
| Research and Development Expense | 22.11M | ||
| Selling, General and Administrative Expense | 7.02M | ||
| Operating Income | -29.13M | ||
| Interest Expense | 491.00K | ||
| Net Income | -27.64M | ||
| Net Income Common Stock | -27.64M | ||
| Net Income Common Stock (USD) | -27.64M | ||
| Consolidated Income | -27.64M | ||
| Earnings per Basic Share | -0.65 | ||
| Earnings per Basic Share (USD) | -0.65 | ||
| Earnings per Diluted Share | -0.65 | ||
| Earning Before Interest & Taxes (EBIT) | -27.15M | ||
| Earning Before Interest & Taxes (USD) | -27.15M | ||
| Weighted Average Shares | 42.81M | ||
| Weighted Average Shares Diluted | 42.81M | ||
| Balance Sheet | |||
| Cash and Equivalents | 244.23M | ||
| Cash and Equivalents (USD) | 244.23M | ||
| Current Assets | 247.32M | ||
| Property, Plant & Equipment Net | 5.91M | ||
| Total Assets | 254.07M | ||
| Debt Current | 3.77M | ||
| Total Debt | 21.93M | ||
| Current Liabilities | 16.65M | ||
| Debt Non-Current | 18.17M | ||
| Total Liabilities | 34.82M | ||
| Accumulated Retained Earnings (Deficit) | -255.51M | ||
| Accumulated Other Comprehensive Income | 17.00K | ||
| Shareholders Equity | 219.25M | ||
| Shareholders Equity (USD) | 219.25M | ||
| Assets Non-Current | 6.75M | ||
| Total Debt (USD) | 21.93M | ||
| Liabilities Non-Current | 18.17M | ||
| Trade and Non-Trade Payables | 4.02M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 387.00K | ||
| Net Cash Flow from Financing | -273.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -20.03M | ||
| Issuance (Purchase) of Equity Shares | -273.00K | ||
| Net Cash Flow from Operations | -19.76M | ||
| Effect of Exchange Rate Changes on Cash | 4.00K | ||
| Share Based Compensation | 3.55M | ||